Today on the Medscape Medical Minute: The FDA approves a new combination drug for migraine; new research finds that most patients who start GLP-1 drugs discontinue them within a year; and Trump administration statements and actions raise questions about the future of US aid for global health. https://www.medscape.com/viewarticle/989872